Does China Have Any Comparative Advantages? If So, How to Counter Them.
The U.S. China Economic and Security Review Commission asked panelists to discuss just how powerful, and important, China supply chains have become to the U.S. economy.
New Thinking Needed on Supply Chain Resilience
The U.S. China Economic and Security Review Commission heard from panelists this week on Washington’s reshoring efforts. Question: Will there be any buyers?
Why Does “Environmental Justice” Only Matter for U.S. Solar, Not SE Asian?
The White House says more solar imports will help spread environmental justice in the U.S. Is Southeast Asia our new Environmental Justice League?
Biden Just Went Against His Voters, Sided with China on Solar
Voters support locally made solar. So why is the Biden administration giving China companies under investigation for trade violations in SE Asia duty-free access to the U.S.?
FDA’s Updated Drug Shortage List Loaded with Critical Medicines
The Food and Drug Administration recently updated its drug shortage list. More than half of the updates include drugs on the essential medicines list.
Senate Puts FDA Re-authorization Deal in Jeopardy Over Infant Formula Crisis
Senator Burr warned the FDA that until the Senate is okay with their response to the infant formula crisis, and present a plan to prevent it in the future, the Generic Drug User Fee Authorization bill might be put on hold.
Tariffs and Inflation: The Dog that Didn’t Bark
Press reports say that Treasury Secretary Janet Yellen is arguing for repealing a broad set of U.S. tariffs, allegedly as a way to fight inflation.
How Trade Remedies Helped U.S. Manufacturers
Solar and steel tariffs helped the industry expand. Here is where the naysayers were wrong about rising prices and market destruction due to anti-dumping charges and other trade remedies.
How The Record Q1 U.S. Trade Deficit Shrank the Economy
For years, mainstream politicians and economists have pooh-poohed America’s huge and growing trade deficits and tried to argue they don’t matter. In the first quarter
Pharma and Trade Deals Top of Mind in China Commission Hearing
The U.S. China Economic and Security Review Commission discussed the tight-linked China-India pharmaceutical supply chain, and tossed aside the notion that sweeping trade deals with India and the region are good ideas.
